EGFR and cholangiocarcinoma: From these findings, we proposed that SG prevents EGFR activation through its binding to the dimerization arm of the untethered conformation of EGFR on CCA cells; thereby, EGFR dimerization is destabilized, and this was validated by the dimerization assay, which showed that SG inhibited ligand-induced EGFR dimerization.